Jesteś tutaj

Najważniejsze publikacje

Wersja PDF
  • Płoski R., Szymański K., Bednarczuk T. The Genetic Basis of Grave’s Disease. Current Genomics 2011, 12
    IF:  2.487
  • Jazdzewski K., Boguslawska J., Jendrzejewski J., Liyanarachchi S., Pachucki J., Wardyn K.A., Nauman A., de la Chapelle A. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC). J Clin Endocrinol Metab. 2011;96(3):E546-53.
    IF: 6.495
  • Płoski R., Brand O.J., Jurecka-Lubieniecka B., Franaszczyk M., Kula D., Krajewski P., Karamat M.A., Simmonds M.J., Franklyn J.A., Gough S.C., Jarząb B., Bednarczuk T. Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts. PLoS One. 2010;5(11):e15512.
    IF: 4.411
  • Jazdzewski K., Liyanarachchi S., Swierniak M., Pachucki J., Ringel M.D., Jarzab B., de la Chapelle A. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA. 2009;106(5):1502-5. 
  • Czarkowski M., Rózanowski K. Polish research ethics committees in the European Union system of assessing medical experiments. Sci Eng Ethics. 2009 2: 201-12.
    IF: 0.913
  • Szybinski Z., Golkowski F., Buziak-Bereza M., Trofimiuk M., Przybylik-Mazurek E., Huszno B., Bandurska-Stankiewicz E., Bar-Andziak E., Dorant B., Kinalska I., Lewinski A., Klencki M., Rybakowa M., Sowinski J., Szewczyk L., Szponar L., Wasik R. Effectiveness of the iodine prophylaxis model adopted in Poland. J Endocrinol Invest. 2008;31(4):309-13
    IF: 1.888
  • Peczkowska M., Erlic Z., Hoffmann M.M., Furmanek M., Cwikla J., Kubaszek A., Prejbisz A., Szutkowski Z., Kawecki A., Chojnowski K., Lewczuk A., Litwin M., Szyfter W., Walter M.A., Sullivan M., Eng C., Januszewicz A., Neumann H.P. Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1. J Clin Endocrinol Metab. 2008; 93:4818-25.
    IF: 6.325
  • Nawrot I., Woźniewicz B., Tołłoczko T., Sawicki A., Górski A., Chudziński W., Wojtaszek M., Grzesiuk W., Sladowski D., Karwacki J., Zawitkowska T., Szmidt J. Allotransplantation of cultured parathyroid progenitor cells without immunosuppression: clinical results. Transplantation. 2007 Mar 27;83(6):734-40.
    IF: 3.640
  • Kurylowicz A., Hiromatsu Y., Jurecka-Lubieniecka B., Kula D., Kowalska M., Ichimura M., Koga H., Kaku H., Bar-Andziak E., Nauman J., Jarzab B., Ploski R., Bednarczuk T. Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease. Genes Immun. 2007 Oct;8(7):532-8.
    IF: 4.088
  • Kavvoura F.K., Akamizu T., Awata T., Ban Y., Chistiakov D.A., Frydecka I., Ghaderi A., Gough S.C., Hiromatsu Y., Ploski R., Wang P.W., Ban Y., Bednarczuk T., Chistiakova E.I., Chojm M., Heward J.M., Hiratani H., Juo S.H., Karabon L., Katayama S., Kurihara S., Liu R.T., Miyake I., Omrani G.H., Pawlak E., Taniyama M., Tozaki T., Ioannidis J.P. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab. 2007 Aug;92(8):3162-70.
    IF: 5.493
  • Grzesiuk W., Nieminuszczy J., Kruszewski M., Iwanienko T., Plazinska M., Bogdanska M., Bar-Andziak E., Królicki L., Grzesiuk E. DNA damage and its repair in lymphocytes and thyroid nodule cells during radioiodine therapy in patients with hyperthyroidism. J Mol Endocrinol. 2006 Dec;37(3):527-32.
    IF: 2.988
  • Czarkowski M., Hilgertner L., Powałowski T., Radomski D., Mikulska M. Is the resistance of large conduit arteries also decreased in thyrotoxic patients with Graves' disease? Thyroid. 2005 Apr;15(4):377-81.
    IF: 2.175
  • Pachucki J., Hopkins J., Peeters R., Tu H., Carvalho S.D., Kaulbach H., Abel E.D., Wondisford F.E., Ingwall J.S., Larsen P.R.. Type 2 iodothyronin deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis. Endocrinology. 2001 Jan;142(1):13-20.
    IF: 4.971
  • Puzianowska-Kuznicka M., Nauman A., Madej A., Tanski Z., Cheng S., Nauman J. Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma. Cancer Lett. 2000 Jul 31;155(2):145-52
    IF: 1.517
  • Hiromatsu Y., Yang D., Bednarczuk T., Miyake I., Nonaka K., Inoue Y. Cytokine profile in eye muscle tissue and orbital fat tissue  from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 2000; 85: 1194-1199
    IF: 5.447
  • Pachucki J., Burmeister L.A., Larsen P.R.. Thyroid hormone regulates hyperpolarization-activated cyclic nucleotide-gated channel (HCN2) mRNA in the rat heart. Circ Res. 1999;85(6):498-503.
    IF: 8.281